Jørg Saberniak
Position: PhD Student, Cardiologist, MD
Phone: 23070000
Email:

Project:

Myocardial function and prediction of ventricular arrhythmias in patients with arrhythmic right ventricular cardiomyopathy.


Supervisors
:

Kristina H Haugaa, MD, PhD, Dept of Cardiology, Oslo University Hospital, Rikshospitalet,Norway

Thor Edvardsen, MD, PhD, FESC, Professor, University of Oslo, Deputy Head, Dept. of Cardiology, Director, Section of Diagnostics and Treatment

Collaborators:

Anders Gaarsdal Holst for the Nordic ARVC registry, MD, Research Fellow, Department of Cardiology, University Hospital Rigshospitalet
Blegdamsvej 9, 2100 Copenhagen,

Professor Jesper Hastrup-Svendsen, MD, PhD, Dept of Cardiology, The Heart Centre, Rigshospitalet, University of Copenhagen, Denmark

Professor Pyotr Platinov, MD, PhD, Lunds Universitetssjukhus, Lund, Sweden


Aim:

  1. Predict malignant ventricular arrhythmias in patients with ARVC
  2. Hjelp differential diagnosis between RVOT- VT and ARVC
  3. Assess right and left ventricular function by novel echocardiographic techniques in patients with ARVC and related the findings with previous sports activity
  4. Perform genotype-phenotype correlations in patients with ARVC.
  5. Examine the impact of sport activity in CPVT patients

Method:

Echocardiography , global left and right ventricular function/ global strain , strain echocardiography, mechanical dispersion

Publications 2011

Hetland A, Haugaa KH, Olseng M, Gjesdal O, Ross S, Saberniak J, Jacobsen M, Edvardsen T Three months treatment with adaptive servo-ventilation improves cardiac function and physical activity in patients with chronic heart failure and Cheyne-Stokes respiration in a prospective randomized controlled trial. Circulation 2011, Nov 2011; 124:

 

 

Author network for Jørg Saberniak by COREMINE medical


Publications 2017

Broch K, Leren IS, Saberniak J, Ueland T, Edvardsen T, Gullestad L, Haugaa KH (2017)
Soluble ST2 is associated with disease severity in arrhythmogenic right ventricular cardiomyopathy
Biomarkers, 22 (3-4), 367-371
PubMed 28067540

Publications 2016

Haland TF, Almaas VM, Hasselberg NE, Saberniak J, Leren IS, Hopp E, Edvardsen T, Haugaa KH (2016)
Strain echocardiography is related to fibrosis and ventricular arrhythmias in hypertrophic cardiomyopathy
Eur Heart J Cardiovasc Imaging, 17 (6), 613-21
PubMed 26873460

Haland TF, Saberniak J, Leren IS, Edvardsen T, Haugaa KH (2016)
Echocardiographic comparison between left ventricular non-compaction and hypertrophic cardiomyopathy
Int J Cardiol, 228, 900-905
PubMed 27894062

Leren IS, Saberniak J, Haland TF, Edvardsen T, Haugaa KH (2016)
Combination of ECG and Echocardiography for Identification of Arrhythmic Events in Early ARVC
JACC Cardiovasc Imaging (in press)
PubMed 27771401

McLeod K, Wall S, Leren IS, Saberniak J, Haugaa KH (2016)
Ventricular structure in ARVC: going beyond volumes as a measure of risk
J Cardiovasc Magn Reson, 18 (1), 73
PubMed 27756409

Saberniak J, Leren IS, Haland TF, Beitnes JO, Hopp E, Borgquist R, Edvardsen T, Haugaa KH (2016)
Comparison of patients with early-phase arrhythmogenic right ventricular cardiomyopathy and right ventricular outflow tract ventricular tachycardia
Eur Heart J Cardiovasc Imaging, 18 (1), 62-69
PubMed 26903598

Publications 2015

Haugaa KH, Haland TF, Leren IS, Saberniak J, Edvardsen T (2015)
Arrhythmogenic right ventricular cardiomyopathy, clinical manifestations, and diagnosis
Europace, 18 (7), 965-72
PubMed 26498164

Kallhovd S, Gjerald SU, Wall ST, Saberniak J, Haugaa K, Maleckar MM (2015)
Localization and not Extent of Fibrofatty Infiltration is the Primary Factor Determining Conduction Disturbance in a Computational Model of Arrhythmogenic Cardiomyopathy
2015 E-HEALTH AND BIOENGINEERING CONFERENCE (EHB)

Leren IS, Hasselberg NE, Saberniak J, Håland TF, Kongsgård E, Smiseth OA, Edvardsen T, Haugaa KH (2015)
Cardiac Mechanical Alterations and Genotype Specific Differences in Subjects With Long QT Syndrome
JACC Cardiovasc Imaging, 8 (5), 501-10
PubMed 25890583

Leren IS, Saberniak J, Majid E, Haland TF, Edvardsen T, Haugaa KH (2015)
Nadolol decreases the incidence and severity of ventricular arrhythmias during exercise stress testing compared with β1-selective β-blockers in patients with catecholaminergic polymorphic ventricular tachycardia
Heart Rhythm, 13 (2), 433-40
PubMed 26432584

McLeod K, Noack M, Saberniak J, Haugaa K (2015)
Structural Abnormality Detection of ARVC Patients via Localised Distance-to-Average Mapping
LECT NOTES COMPUT SC, 8896, 177-186

Publications 2014

Manotheepan R, Saberniak J, Danielsen TK, Edvardsen T, Sjaastad I, Haugaa KH, Stokke MK (2014)
Effects of individualized exercise training in patients with catecholaminergic polymorphic ventricular tachycardia type 1
Am J Cardiol, 113 (11), 1829-33
PubMed 24837260

Saberniak J, Hasselberg NE, Borgquist R, Platonov PG, Sarvari SI, Smith HJ, Ribe M, Holst AG, Edvardsen T, Haugaa KH (2014)
Vigorous physical activity impairs myocardial function in patients with arrhythmogenic right ventricular cardiomyopathy and in mutation positive family members
Eur J Heart Fail, 16 (12), 1337-44
PubMed 25319773

Publications 2013

Hetland A, Haugaa KH, Olseng M, Gjesdal O, Ross S, Saberniak J, Jacobsen MB, Edvardsen T (2013)
Three-month treatment with adaptive servoventilation improves cardiac function and physical activity in patients with chronic heart failure and cheyne-stokes respiration: a prospective randomized controlled trial
Cardiology, 126 (2), 81-90
PubMed 23941739